跳至主要内容
临床试验/NCT05174910
NCT05174910进行中(未招募)不适用

Investigation of the Benefit of Using an Autologous Platelet-rich Fibrin Matrix (Obsidian ASG®) for Treatment of Anastomosis During Rectal Surgery - a Single-blind, Randomized, Multicenter Pilot Study

Vivostat26 个研究点 分布在 5 个国家目标入组 250 人开始时间: 2021年12月23日最近更新:
适应症

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
250
试验地点
26
主要终点
Anastomosis insufficiency [yes/no]

研究概览

简要总结

Anastomotic insufficiency remains one of the most significant problems after rectal resection.The complications following anastomotic insufficiency leads to increased morbidity and mortality with subsequent prolongation of hospital stay and higher costs.

This study is an investigation of the benefit of using an autologous platelet-rich fibrin matrix (Obsidian ASG®) for treatment of anastomosis during rectal surgery - a single-blind, randomized, multicenter pilot study with enrollment of 2x125 patients

The main objective of the study is to investigate on an exploratory basis whether the use of Obsidian ASG® during rectal resection reduces the frequency of postoperative anastomotic insufficiency compared to standard anastomotic technique.

The secondary objectives of the study are to investigate on an exploratory basis:

  • The frequency of anastomotic insufficiency (ISREC Criteria) severity
  • Staple line bleeding requiring surgical intervention
  • The duration of postoperative hospitalization are reduced when using Obsidian ASG ® compared with standard anastomotic treatment alone.

are reduced when Obsidian ASG ® is added to the standard of anastomotic treatment compared with standard anastomotic treatment alone.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • The following inclusion criteria will be considered:
  • Written informed consent
  • Age > 18 years
  • Indication for elective oncological rectal resection in the presence of malignant rectal disease and the lower edge of the tumor, measured from the anal verge with the rigid rectoscope, ≤ 14cm
  • Use of a circular anastomosis using the "double stapling technique"(6) during creation of the anastomosis
  • Expected availability within the maximum 45-day period of study participation
  • The use of "golden standard" stapling technology devices; 3 rows endo linear stapler; 2 rows circular stapling devices should be used in an open and laparoscopic approach

排除标准

  • The following exclusion criteria will be considered:
  • Pregnancy, or the non-exclusion of pregnancy (for women of childbearing potential). In the case of menopause having occurred more than 2 years ago or postmenopausal sterilization or surgical sterilization, the authorized physician is free to classify the female study participant as non-pregnant, so that the pregnancy test otherwise required at the beginning of study participation (or during subject screening) may be omitted.
  • Risk of pregnancy occurring while taking part in the study in women not meeting at least one of the following criteria: Onset of menopause more than 2 years ago, postmenopausal sterilization, surgical sterilization, a promise to use contraception (with hormones, coil or diaphragm/condom + spermicide), while enrolled in the study) In the case of onset of menopause more than 2 years ago, postmenopausal sterilization or surgical sterilization, the authorized doctor is free to classify the patient in question as infertile. Furthermore, it is at the discretion of the authorized physician to classify the patient in question on the basis of continuous inpatient care in such a way that the occurrence of pregnancy during participation in the study can be ruled out ("continuous determination of the absence of pregnancy"). If one of the above classifications applies, further measures to ensure that a pregnancy does not occur during the patient's participation in the study may not be required.
  • Breastfeeding period
  • Lack of legal capacity
  • Vulnerable persons according to the law
  • Comorbidity with the potential for relevant impairment of anastomosis durability (leukemia, cirrhosis of the liver, Child Pugh C, etc.)
  • Preoperative anemia with Hb <8g/dL
  • Participating in another study
  • Patients on Aspirin not able to stop using Aspirin for medical reasons minimum 3 days before taking the blood sampling.
  • Patients on Clopidogrel not able to stop using Clopidogrel for medical reasons minimum 7 days before blood sampling.
  • Patients on other platelet aggregation inhibitor therapies
  • Contraindication for Obsidian ASG®
  • Surgical technique of transanal total mesorectal excision (TaTME)
  • Application of a circular powered stapler in the course of anastomosis supply with GSTTM technology or a 3 row circular stapler use while creating the study anastomosis

结局指标

主要结局

Anastomosis insufficiency [yes/no]

时间窗: 45 days

Anastomosis insufficiency after colorectal surgery with primary anastomosis

次要结局

  • Staple suture line bleeding requiring surgical intervention [yes, with surgical intervention / yes, without surgical intervention / no](45 days)
  • Anastomotic insufficiency [0/A/B/C]*(45 days)
  • Postoperative hospital length of stay [days](45 days)

研究者

发起方
Vivostat
申办方类型
Industry
责任方
Sponsor

研究点 (26)

Loading locations...

相似试验